• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.

作者信息

Fiore Mathieu, Gerbaud Edouard, Coste Pierre, Cetran Laura, Marchand Hugo, Seguy Benjamin

机构信息

Laboratory of Hematology, Reference Center for Platelet Disorders, University Hospital of Bordeaux, Pessac, France.

Cardiovascular Intensive Care Unit, Cardiologic Hospital, University Hospital of Bordeaux, Pessac, France.

出版信息

Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.

DOI:10.1016/j.resuscitation.2018.06.032
PMID:29969644
Abstract
摘要

相似文献

1
Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的院外心脏骤停昏迷幸存者中，坎格雷洛实现最佳血小板抑制作用。
Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.
2
Ticagrelor Versus Clopidogrel in Comatose Survivors of Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention and Hypothermia: A Randomized Study.替格瑞洛与氯吡格雷用于接受经皮冠状动脉介入治疗及低温治疗的院外心脏骤停昏迷幸存者：一项随机研究
Circulation. 2016 Dec 20;134(25):2128-2130. doi: 10.1161/CIRCULATIONAHA.116.024872.
3
Periprocedural platelet inhibition with cangrelor in P2Y-inhibitor naïve patients with acute coronary syndromes - A matched-control pharmacodynamic comparison in real-world patients.在未使用P2Y抑制剂的急性冠状动脉综合征患者中使用坎格雷洛进行围手术期血小板抑制——真实世界患者的配对对照药效学比较
Int J Cardiol. 2016 Nov 15;223:848-851. doi: 10.1016/j.ijcard.2016.08.270. Epub 2016 Aug 17.
4
Randomized Comparison of Oral P2Y-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial.从坎格雷洛转换时口服 P2Y 受体抑制剂加载策略的随机比较：ExcelsiorLOAD2 试验。
JACC Cardiovasc Interv. 2017 Jan 23;10(2):121-129. doi: 10.1016/j.jcin.2016.10.004.
5
The impact of mild therapeutic hypothermia on platelet reactivity in comatose survivors of cardiac arrest with acute myocardial infarction treated with ticagrelor.在接受替格瑞洛治疗的伴有急性心肌梗死的心脏骤停昏迷幸存者中，亚低温治疗对血小板反应性的影响。
Cardiol J. 2024;31(3):472-478. doi: 10.5603/CJ.a2022.0029. Epub 2022 May 6.
6
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.在初次血管成形术期间，因严重呼吸困难停用坎格雷洛和替格瑞洛。
J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.
7
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction.在现实世界中患有ST段抬高型心肌梗死的患者进行直接经皮冠状动脉介入治疗期间及之后，坎格雷洛与替格瑞洛联合使用可提供持续且强效的P2Y12抑制作用。
Platelets. 2017 Jun;28(4):414-416. doi: 10.1080/09537104.2016.1246714. Epub 2016 Nov 25.
8
Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者从坎格雷洛转换为替格瑞洛的安全性和耐受性
Am J Cardiol. 2017 Aug 1;120(3):359-361. doi: 10.1016/j.amjcard.2017.04.034. Epub 2017 May 10.
9
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.经皮冠状动脉介入治疗患者中坎格雷洛、普拉格雷、替格瑞洛和氯吡格雷的比较：一项网状Meta分析。
Cardiovasc Revasc Med. 2017 Mar;18(2):79-85. doi: 10.1016/j.carrev.2016.10.005. Epub 2016 Oct 21.
10
Pharmacodynamic effects during the transition between cangrelor and ticagrelor.坎格雷洛与替格瑞洛转换期间的药效学效应。
JACC Cardiovasc Interv. 2014 Apr;7(4):435-42. doi: 10.1016/j.jcin.2013.08.017. Epub 2014 Mar 19.

引用本文的文献

1
Cangrelor in Patients Undergoing Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest.坎格雷洛用于院外心脏骤停后接受经皮冠状动脉介入治疗的患者。
J Clin Med. 2024 Dec 27;14(1):76. doi: 10.3390/jcm14010076.
2
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.坎格雷洛与替格瑞洛碾碎片在急性心肌梗死合并心原性休克患者中的应用：随机、双盲 DAPT-SHOCK-AMI 试验的原理和设计。
EuroIntervention. 2024 Oct 21;20(20):e1309-e1318. doi: 10.4244/EIJ-D-24-00203.
3
Immediate Platelet Inhibition Strategy for Comatose Out-of-Hospital Cardiac Arrest Survivors Undergoing Percutaneous Coronary Intervention and Mild Therapeutic Hypothermia.
针对接受经皮冠状动脉介入治疗和轻度治疗性低温的昏迷院外心脏骤停幸存者的即时血小板抑制策略。
J Clin Med. 2024 Apr 6;13(7):2121. doi: 10.3390/jcm13072121.
4
Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis.院外心脏骤停后行经皮冠状动脉介入治疗患者的心血管死亡率和发病率：系统评价和荟萃分析。
EuroIntervention. 2021 Feb 5;16(15):e1245-e1253. doi: 10.4244/EIJ-D-20-00221.
5
High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死低温心脏骤停幸存者从坎格雷洛转换为替格瑞洛后血小板高反应性。
J Clin Med. 2020 Feb 21;9(2):583. doi: 10.3390/jcm9020583.